- UID
- 389754
- 热情
- 5259
- 人气
- 6018
- 主题
- 61
- 帖子
- 479
- 精华
- 1
- 积分
- 5925
- 分享
- 0
- 记录
- 0
- 相册
- 1
- 好友
- 3
- 日志
- 0
- 在线时间
- 1444 小时
- 注册时间
- 2014-10-3
- 阅读权限
- 30
- 最后登录
- 2024-12-26
   
升级   18.5% - UID
- 389754
- 热情
- 5259
- 人气
- 6018
- 主题
- 61
- 帖子
- 479
- 精华
- 1
- 积分
- 5925
- 阅读权限
- 30
- 注册时间
- 2014-10-3
|
Novavax 今日回复
Novavax has a manufacturing partnership with Serum Institute of India, the world’s largest vaccine manufacturer by volume, which will supply initial doses to New Zealand. The approval for provisional registration will later be supplemented with data from additional manufacturing sites in the Novavax global supply chain.
Initial supply of the vaccine is expected to arrive in New Zealand in the coming weeks – where it will undergo local testing. We will work diligently with regulatory authorities and our partners, to expedite the final steps to get our vaccine to the public. We are working closely with our partners on supply schedules, which will accommodate regional and global needs |
|